Show an ad over header. AMP

I am the second

Why waiving vaccine patents won't quickly fix the world's shortage

It will take more than waiving patent protections for coronavirus vaccines — which the Biden administration now says it supports — to fix the gaping global divide in access.

Why it matters: Waiving drug companies' intellectual property rights risks setting a bad precedent for future investment in new drugs. And that risk may not be worth it without additional steps to meaningfully increase the availability of shots across the world.

Keep reading... Show less

Related Articles

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories